General and specific laboratory parameters within the scope of tumor after-care in gynecologic malignancies and breast cancer
Kreienberg, R.
Der Gynakologe 22(1): 55-62
1989
ISSN/ISBN: 0017-5994 PMID: 2653979 Document Number: 344274
Document emailed within 1 workday
Related Documents
Aoki, D.; Hirasawa, A.; Susumu, N. 2005: Diagnostic significance of tumor markers for gynecologic malignancies Gan to Kagaku Ryoho. Cancer and ChemoTherapy 32(3): 411-416Inoue, M.; Saitoh, J.; Abe, Y.; Inoue, Y.; Ueda, G.; Tanizawa, O.; Gamoh, Y.; Dan, A.; Satoh, T. 1985: Clinical significance of CA 19-9 as a tumor marker for gynecologic malignancies Nihon Sanka Fujinka Gakkai Zasshi 37(11): 2411-2414
Inoue, M.; Fujita, Y.; Abe, Y.; Inoue, Y.; Ueda, G.; Tanizawa, O.; Minagawa, J.; Yamada, T.; Ohashi, K.; Ozaki, M. 1985: Tissue polypeptide antigen as a tumor marker for gynecologic malignancies Nihon Sanka Fujinka Gakkai Zasshi 37(9): 1799-1805
Slate, W.G. 1980: From the Delaware Cancer Network. Gynecologic malignancies Delaware Medical Journal 52(1): 5
Mujagić, Z.; Mujagic, H.; Prnjavorac, B. 2004: The relationship between circulating carcinoembryonic antigen (CEA) levels and parameters of primary tumor and metastases in breast cancer patients Medicinski Arhiv 58(1): 23-26
Gupta, R.; Morton, D. 1995: Detection and comparison of a 90-kd glycoprotein tumor-associated antigen-specific immune-complexes with cea and ca15-3 in breast-cancer International Journal of Oncology 7(4): 741-747
Hsieh, C.Y.; Chang, D.Y.; Huang, S.C.; Yen, M.L.; Juang, G.T.; Ouyang, P.C. 1989: Serum squamous cell carcinoma antigen in gynecologic malignancies with special reference to cervical cancer Journal of the Formosan Medical Association 88(8): 797-800
Zabalegui, N.; de Cerio, Aón.López-Díaz.; Inogés, S.; Rodríguez-Calvillo, M.; Pérez-Calvo, J.; Hernández, M.; García-Foncillas, Jús.; Martín-Algarra, S.; Rocha, E.; Bendandi, M. 2004: Acquired potential N-glycosylation sites within the tumor-specific immunoglobulin heavy chains of B-cell malignancies Haematologica 89(5): 541-546
Fujimitsu, R.; Nomoto, S.; Kuwabara, Y.; Shimakura, M.; Yoshimitsu, K. 2012: Second malignancies in breast cancer patients after radiotherapy Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 7): 97-100
Curtis, M.A. 2003: New monoclonal antibodies for hematologic malignancies (and breast cancer) Medicine and Health Rhode Island 86(8): 256-257
Le Bouedec, G.; Pingeon, J.M.; Fondrinier, E.; Kauffmann, P.; Dauplat, J. 1995: Gynecologic monitoring of tamoxifen treatment of breast cancer Revue Francaise de Gynecologie et d'Obstetrique 90(7-9): 379-382
Baggs, W.J.; Amor, R.L. 1979: Thermographic screening for breast cancer in a gynecologic practice Obstetrics and Gynecology 54(2): 156-162
Sarkar, M.; Konar, H.; Raut, D.K. 2011: Knowledge and health care-seeking behavior in relation to gynecological malignancies in India: a study of the patients with gynecological malignancies in a tertiary care hospital of Kolkata Journal of Cancer Education: the Official Journal of the American Association for Cancer Education 26(2): 348-354
Schaffer, P.; Renaud, R.; Gérard, A.; Gairard, B. 1992: The general practitioner and screening for cancer of the breast. Study of a sample of 200 general practitioners in the Bas-Rhin Journal de Gynecologie Obstetrique et Biologie de la Reproduction 21(2): 163-171
Blackman, K.E.; Fingert, H.J.; Fuller, A.F.; Meitner, P.A. 1994: The fluorescent cytoprint assay in gynecological malignancies and breast cancer. Methodology and results Contributions to Gynecology and Obstetrics 19: 53-63
Kaunitz, A.M. 1996: Depot medroxyprogesterone acetate contraception and the risk of breast and gynecologic cancer Journal of Reproductive Medicine 41(5 Suppl): 419-427
Nandakumar, A.; Anantha, N.; Venugopal, T.C. 1998: Population-based survival from breast and cervical cancer and lymphoreticular malignancies in Bangalore, India Iarc Scientific Publications 145: 61-68
Nandakumar, A.; Anantha, N.; Venugopal, T.C. 1998: Population-based survival from breast and cervical cancer and lymphoreticular malignancies in Bangalore, India Iarc Scientific Publications 145: 61-68
Nahhas, W.A. 1975: The curability of gynecologic malignancies Le Journal Medical Libanais. Lebanese Medical Journal 28(1): 123-131
Sparano, J.A. 1998: Compilation of phase i and Ii trial data of docetaxel and doxorubicin in the treatment of advanced breast cancer and other malignancies Seminars in Oncology 25(6 Suppl 13: 10-15